Name | Lambrolizumab |
Synonyms | Lambrolizumab Pembrolizumab pembrolimumab Pembrolizumab (anti-PD-1) PEMBROLIMUMAB PD-1 1374853-91-4 |
CAS | 1374853-91-4 |
EINECS | 807-012-2 |
Storage Condition | − 20 ℃, dark |
In vivo study | In addition to melanoma and lung cancer, pembrolizumab is also effective in other advanced solid tumors and hematologic malignancies. Pembrolizumab has an acceptable range of side effects and has anti-tumor activity in patients with advanced non-small cell lung cancer. |